Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are demonstrably more effective in clinical trials. The most recent earnings reports ...

With Novo Nordisk’s name already synonymous ... from its FLOW trial showing that a once-weekly 1-mg dose of semaglutide—the molecule behind Ozempic and Wegovy—helped combat major kidney ...

Your doctor can prescribe a further 1-mg ... buy Ozempic is through insurance companies. If you have commercial or private insurance, you can get Ozempic for as little as $25 with a Novo Nordisk ...

manufacturer Novo Nordisk and Health Canada said on Friday. "We are experiencing a temporary supply disruption with the Ozempic 1 mg (injection) pen due to the combination of overall global supply ...

At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish ...

Novo Nordisk's U.S.-listed and domestic shares rose Wednesday after analysts from UBS upgraded the Danish drugmaker's stock ...

Novo Nordisk also boasted a 55.6% share of the GLP-1 drug space, compared to 54.4% as of August 2023. The company's most famous brands, Wegovy and Ozempic, are both GLP-1s. They have helped Novo ...